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Abstract: This project attempts to identify anatomic features that predict the 
range of the ‘normal’ endocochlear potential in young inbred mice.  Cochlear 
lateral wall histologic metrics were compared in recombinant inbred (RI) mouse 
strains formed from BALB/c and C57BL/6 mice.  
 
  Walkonis 
 
 
ACKNOWLEDGEMENTS 
 
I would like to thank the following people for their time, effort, and guidance, without which this  
 
project would not have been possible. 
 
Kevin K. Ohlemiller, Ph.D., Capstone Advisor 
 
Keiko Hirose, M.D., Second Reader 
 
Patricia M. Gagnon, M.S. 
 
Pat Keller 
 
 
ii 
 
  Walkonis 
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS .……………………………………………………………………...ii 
LIST OF FIGURES .……………………………………………………………………………...2 
INTRODUCTION ………………………………………………………………………………..3 
 Forms of presbycusis …………………………………………………………………….3 
 Strial architecture and the generation of the EP ………………………………………….4 
 Strial Presbycusis in the Mongolian Gerbil ……………………………………………...5 
 Strial Presbycusis in Mice ………………………………………………………………..6 
 Pursuing the genetics of EP decline using Recombinant Inbred Mouse Strains ……......8 
METHODS ……………………………………………………………………………………….9 
RESULTS ……………………………………………………………………………………….11 
DISCUSSION …………………………………………………………………………………...13 
 Clinical Implications ……………………………………………………………………15 
REFERENCES ………………………………………………………………………………….16 
   
1 
 
Walkonis 
 
LIST OF FIGURES 
 
FIGURE 1:  Schematic of membranous cochlea …………………………………………………4 
FIGURE 2:  Radial section of stria vascularis and spiral ligament ………………………………5 
FIGURE 3:  EP vs. strial metrics in BALB and B6 mice ………………………………………...7 
FIGURE 4:  Comparison of EP in BALB and B6 mice ………………………………………….7 
FIGURE 5:  Young normal EP values in CxB strains ……………………………………………9 
FIGURE 6:  Lower base section of CxB11 mouse from current study …………………………10 
FIGURE 7:  Strial thickness by location ………………………………………………………...11 
FIGURE 8:  Marginal cells by location …………………………………………………………12 
FIGURE 9:  Ligament thickness by location ……………………………………………………12 
FIGURE 10:  Total capillaries by location ……………………………………………………...13 
   
2 
 
Walkonis 
 
Introduction 
 Age-related hearing loss (ARHL), also known as presbycusis, is one of the most common 
diseases affecting the aged.  According to the National Institute on Deafness and Other 
Communication Disorders, one in three people above age 60 and half of those over 85 have 
hearing loss (2001).  This condition continues to proliferate as the population grows and medical 
advances provide a longer lifespan.  Treatments such as hearing aids, hearing assistive 
technology, and cochlear implants have been very successful in improving the quality of life for 
those with presbycusis, but identification and protection of the anatomic structures that underlie 
this pathology would be even more significant. 
 
Forms of presbycusis 
 In a pioneering study of 21 presbycusic human temporal bones, Schuknecht and Gacek 
(1993) identified three major forms of presbycusis that are most commonly accepted today.  
These include sensory (associated with initial pathology of the organ of Corti), neural (primary 
loss of neurons, while hair cells survive), and strial (degeneration of stria vascularis and 
subsequent reduction of the endocochlear potential (EP)).  Each of these forms was posited to 
have its own set of environmental and genetic causes, and to give rise to a particular audiometric 
shape.  Strial presbycusis has been claimed by some to represent the major and ‘purest’ form 
(Gates and Mills, 2005), being less easily confused with noise injury, and potentially arising 
from true ‘aging-like’ processes.  The foundations of strial presbycusis have relied largely on a 
small set of temporal bones, and until recently, only a single clear animal model, namely the 
Mongolian gerbil (Schulte and Schmiedt, 1992; Gratton and Schulte, 1995; Spicer and Schulte, 
2005).  The recent appearance of suitable mouse models (Ohlemiller, 2009) has offered new 
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insights regarding when and how strial presbycusis arises.  One of these models forms the basis 
of the present study. 
 
Strial architecture and the generation of the EP  
 The stria vascularis is a three-layered, hightly-vascularized epithelium found on the 
lateral cochlear wall (Fig.1).  It is the central structure involved in normal endolymph 
composition and EP generation (Wangemann, 2002).   
             
Figure 1: Schematic view of a portion of the 
membranous cochlea.  Reprinted with 
permission from Bohne, 2008. 
The ~90-100 mV EP is the driving force of sensory conduction in the cochlea, and requires a 
carefully regulated supply of K+—by far the dominant ion in endolymph— as its current carrier.  
The essential strial elements for EP generation are the Kcnj10 channel, located in the 
intermediate cells, and the Na+/K+-ATPase and Na+/K+/Cl- co-transporter in marginal cells.  The 
DC electric potential that is the EP is created by positive charge concentration in endolymph in 
relation to perilymph (Salt et al., 1987; Takeuchi et al., 2000; Wangemann, 2006; Ohlemiller, 
2009). 
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Essentially all individuals will show some degree of strial degeneration with age, 
manifested in the form of strial thinning, capillary loss, and loss of all three major cell types: 
marginal cells, intermediate cells, and basal cells (Fig. 2).   
                                                  
Figure 2: Radial section of stria vascularis and 
spiral ligament.  Reprinted with permission 
from Bohne, 2008. 
The stria, however, appears to possess an immense amount of extra functional capacity, so that 
only some people will exhibit EP decline and resulting hearing loss.  If the stria degenerates to 
some threshold level, generation of the EP is impaired, resulting in increased hearing thresholds 
(Pauler et al., 1988).  Strial presbycusis can manifest itself any time during the third to sixth 
decade of life.  Purportedly, it is characterized by a flat or slightly sloping audiometric pattern 
which progresses over time (Schuknecht, 1964; Pauler, Schuknecht, and White, 1988; 
Schuknecht and Gacek, 1993).   
 
Strial Presbycusis in the Mongolian Gerbil 
 While human temporal bones have been studied in the past and provided much insight 
into the pathology of presbycusis, EP has never been measured in humans.  For this reason, 
researchers have turned to animal models in order to correlate declining EP with specific 
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anatomic features.  Some of the first animals to be studied in this regard were Mongolian gerbils.  
In 1992, Schulte and Schmiedt chose to study gerbils because of their well characterized auditory 
system, short life span, and audibility curve that closely parallels that of humans.  They found 
that strial atrophy increases in prevalence and severity with age, supporting the idea that loss of 
strial function leads to a lowering of the EP, subsequently elevating pure tone thresholds.  Also 
of note was the tendency of strial atrophy to be more prevalent in the apex earlier in life (Schulte 
and Schmiedt, 1992).  Several years later Gratton and Schulte asserted that EP decline is 
associated with capillary loss, and that atrophy of the stria is secondary to the lack of vasculature 
(1995).  More recently, however, studies have shown that degeneration begins in the marginal 
cells, with capillary loss being secondary.  Specifically, atrophy begins at the secondary 
processes of the marginal cells, followed by the primary processes (Spicer and Schulte, 2005). 
 
Strial Presbycusis in Mice 
In neither humans nor animals is strial presbycusis likely to represent a homogeneous 
process.  But with forever limited human temporal bone samples, virtually no functional 
information in humans, and only a single animal model, there were few resources for uncovering 
multiple etiologies.  In 2006, Ohlemiller, Lett, and Gagnon sought to establish the first naturally 
occurring mouse model of strial presbycusis.  In this study they compared cochlear lateral wall 
metrics in BALB/cJ (BALB) mice to those in C57BL/6J (B6) mice.  The EP in the BALB mice 
decreased over their lifespan, concurrent with loss of marginal cells and thinning of the spiral 
ligament.  B6 mice maintained a stable EP while retaining more marginal cells and spiral 
ligament thickness.  Interestingly, the early ‘normal’ EP in BALBs was also slightly lower than 
in B6, as were initial marginal cell density and ligament thickness (Fig. 4).  In this study, 
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marginal cell density and ligament thickness were found to be the most predictive of EP in the 
two strains (Fig. 3).  
 
Figure 3 – Relation between basal cochlear turn EP and spiral ligament thickness (top row), strial marginal cell density (middle 
row), and strial capillary basement membrane thickness (bottom row) in female B6 and BALB/c mice. Each plot compares young 
(<3 months) and old (>19 months) within strain. Data for each animal are means from examination of upper basal turn in 5 sections.   
Reprinted with permission from Ohlemiller, 2006. 
 
    
Figure 4 – Comparison of cochlear basal turn EP in B6 and 
BALB/c mice for ages up to 26 months. BALBs show EP 
reduction in some animals by 19 months (female only tested for 
ages >13 months). B6 (both genders at all ages) show no 
significant EP reduction.  Initial ‘normal’ EPs in BALBs are 
~10 mV lower than in B6.  Reprinted with permission from 
Ohlemiller, 2006. 
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Surprisingly, changes in microvasculature such as capillary loss and capillary basement 
membrane thickening did not appear to be factors (Ohlemiller et al., 2006; Ohlemiller, 2009).  
These findings agree with earlier work identifying marginal cells as the first structures to 
degenerate in strial presbycusis in humans and animals (Schuknecht, 1974; Spicer and Schulte, 
2005).  However, they also added a previously unreported relation between strial marginal cell 
density and spiral ligament thickness.  Subsequent studies supported this relation in another 
mouse model, the aging B6 albino mouse (Ohlemiller et al., 2009).  The mouse results suggested 
a causal link between mildly reduced marginal cell numbers, a thin spiral ligament, and a 
reduced EP early in life.  They further suggested that these are risk factors for strial presbycusis 
later in life.  Finally, if these features co-occur only in certain individuals, they may be 
genetically linked, and such individuals may carry ‘strial presbycusis genes’. 
 
Pursuing the genetics of EP decline using Recombinant Inbred Mouse Strains 
 The stark differences in EP and cochlear lateral wall attributes between BALB and B6 
mice suggest that these strains carry different alleles at one or more responsible gene loci.  When 
two mouse strains usefully differ, this presents an opportunity to test the genetic bases of those 
differences.  Typically, this is done by crossing the two strains and examining the phenotype of 
F1 hybrids, then F2 or N2 mice.  In the case of BALB and B6 mice, however, there exists an 
alternative, in the form of 13 recombinant inbred (RI) mouse strains formed from these.  RI 
strains are created by crossing two strains of mice, then creating sublines through sib crosses.  
This process essentially fixes a random mix of BALB and B6 genomes.  Each of 13 established 
CxB RI strains (CxB1-CxB13) possess unique genomes and their related phenotypes.  If a small 
number of genes are responsible for EP and lateral wall differences between BALB and B6 mice, 
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then some of the 13 RI strains will fix those same genes.  If, say, the ‘BALB EP phenotype’ is 
due to one gene that has few modifiers, then roughly half of the CxB strains should be BALB-
like.  If, however, the phenotype is associated with two genes, then only a quarter of the RI 
strains should be BALB-like.  Pilot experiments in the Ohlemiller laboratory have established an 
ordering of mean ‘normal’ EPs for 12 of the 13 RI strains.  It was found that there is no clear 
delineation between BALB-like and B6-like RI strains.  Nevertheless, ordering the 12 RI strains 
by mean EP yielded strains with significantly different EPs at each end of the continuum (Fig. 5).  
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Figure 5: Young normal EP 
values  in CxB strains.  Strains 
have been ordered bu mean EP 
(Ohlemiller, 2010, unpublished). 
If the strains at opposite ends of the continuum show significantly different marginal cell 
densities and thicknesses of spiral ligament, it will argue that those strains fix the same alleles of 
(probably multiple) genes as to BALB and B6 mice.  This expectation forms the foundation of 
this study. 
        
Methods 
 All procedures were approved by the Washington University Institutional Animal Care 
and Use Committee.  The sample was comprised of 4 recombinant inbred strains with EPs at the 
extremes of the distribution.  Thus the two strains with the highest EP early in life (CxB9 and 
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CxB10) were compared with the two with the lowest EP early in life (CxB5 and CxB11) (Fig. 5).  
Mice included both genders and ranged from 2-4 months in age.  Plastic-embedded left cochleae 
from 6 mice of each strain were sectioned in the mid-modiolar plane.  Fifty 4µm sections were 
taken from each animal, spanning 200µm through the mid-modiolar core.   
 
 
Figure 6:  Lower base section of CxB11 mouse from the current study. 
Ten sections from each mouse were analyzed at 3 locations:  lower base, upper base, and lower 
apex.  Metrics included marginal cell density, strial thickness, spiral ligament thickness, and 
capillary density.  Marginal cells were counted in a linear 80µm section of the mid-point of the 
stria.  Strial thickness was measured orthogonal to the midpoint, and ligament thickness was 
measured along a co-linear axis.  Capillaries were counted along the entire profile of each stria.  
Metrics were obtained using a Nikon Optiphot™ light microscope with a 100x oil objective and 
a calibrated grid ocular. 
 Ten estimates for each animal were averaged to obtain overall means for each of the four 
histological metrics.  Statistical analyses included a two way analysis of variance (ANOVA) 
10 
 
Walkonis 
 
(metric x strain, cochlear location), followed by pairwise Bonferroni multiple comparisons tests 
(SIGMASTAT).  Tests yielding a p-value less than 0.05 were considered to be significant.   
 
Results 
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Figure 7:  Average strial thickness measures taken at 3 locations: lower base, 
upper base, and lower apex.   
 
  
As shown in Figure 7, strial thickness was similar at all three locations in all four strains.  
There appeared no significant differences by strain. 
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Figure 8:  Average marginal cell densities measured at 3 locations: lower base, 
upper base, and lower apex.  Significant difference denoted by [*].  
  
CxB9, CxB5, and CxB11 strains all have similar marginal cell densities at each location. 
However, CxB10 mice have overall significantly greater marginal cell density (Fig. 8).  
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 Figure 9:  Average ligament thickness at three locations:  lower base, upper 
base, and lower apex.  Significant differences denoted by [*]. 
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Not surprisingly, the spiral ligament becomes progressively thinner from the lower base 
to the lower apex.  Overall, CxB10 mice showed a significantly thinner ligament than all other 
strains examined.  By contrast, CxB5 mice—a ‘low EP’ strain—showd a significantly thicker 
ligament than all other strains.  Differences were most pronounced in the lower base (Fig. 9). 
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Figure 9: Average capillary densities measured at 3 locations: lower base, upper 
base, and lower apex. 
 
 Capillary density is similar for all strains at all locations, with fewer capillaries overall at 
the lower apex.  There appeared no significant differences by strain (Fig. 10). 
 
Discussion 
 In 2006, Ohlemiller and colleagues found marginal cell density and ligament thickness to 
be the most predictive of the EP in BALB mice, and the best predictors of EP differences 
between and BALB and B6 mice.  When plotting basal cochlear turn EP against spiral ligament 
thickness and marginal cell density, a relation between strial marginal cell density and spiral 
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ligament thickness emerged (Fig. 3).  These findings suggested a causal link between mildly 
reduced marginal cell numbers, a thin spiral ligament, and a reduced EP early in life.  It was also 
postulated that these could be genetically linked risk factors for strial presbycusis in adulthood.  
The present study suggests that ligament thickness and marginal cell density need not be related 
to one another.  This is perhaps most evident when considering the data from CxB10 mice.  
These mice were found to have significantly greater marginal cell density than the remaining 
three strains.  If there was, in fact, a relation between marginal cell density and ligament 
thickness, one would expect the CxB10 mice to also have the thickest ligament measures.  
Instead, the current data indicate that this strain has the thinnest spiral ligament.  Overall, there 
appeared no tendency for mice from the two strains with the highest EP to have more marginal 
cells, or a thicker ligament.  Likewise, there appeared no tendency for mice from the two strains 
having the lowest EP to possess fewer marginal cells or a thinner ligament. 
The published observations in BALB mice (Ohlemiller et al., 2006) suggest that these 
mice segregate alleles that jointly promote a smaller marginal cell population and a thinner spiral 
ligament early in life.  While it remained unclear whether and how these interact, both seem tied 
to a somewhat lower EP early in life in BALBs.  If these traits are tied to the same gene, then RI 
strains showing a BALB-like EP should also show BALB-like marginal cell density and 
ligament thickness.  Conversely, if these traits are tied to different genes, then the two traits 
should prove separable across the RI strains.  The present data support the latter scenario, 
suggesting that multiple genes underlie the BALB lateral wall phenotype.  Even if that is the 
case, one still might have expected EP to follow one of these traits, most likely marginal cell 
density.  However, the present data indicate that, when marginal cell density and ligament 
thickness are separated, the EP follows neither reliably.  It may be that both of these traits (and 
14 
 
Walkonis 
 
their underlying alleles) must coincide to exert a strong effect on the average EP.  The nature of 
such interactions remains to be explored. 
 
Clinical Implications 
 Practical and ethical limitations to the study of presbycusis in humans make animal 
studies essential.  It has been posited that BALB/c mice harbor alleles at one or more genes that 
promote EP decline late in life.  Early modest EP reduction in these mice, and its anatomic 
correlates, have been proposed to constitute early indicators of the later EP decline.  If so, then 
the genes responsible in BALBs may constitute ‘pro-strial presbycusis’ genes.  Whether any of 
the RI strains exhibit late-life EP decline has not been determined.  If there exists a link between 
marginal cell density, spiral ligament thickness and late-life EP decline, the present findings 
suggest that BALBs harbor multiple such genes, and further, that these must coincide for EP 
decline to manifest.  Whatever these genes are, they may exert similar effects in humans.   
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